Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation

Incorporating 18FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation

Abstract Background To investigate whether the incorporation of 18FDG-PET into the automatic treatment planning process may be able to decrease the dose to active bone marrow (BM) for locally advanced anal cancer patients undergoing concurrent chemo-radiation (CHT-RT). Methods Ten patients with loca...

Full description

Bibliographic Details
Main Authors: Pierfrancesco Franco, Christian Fiandra, Francesca Arcadipane, Elisabetta Trino, Francesca Romana Giglioli, Riccardo Ragona, Umberto Ricardi
Format: Article
Language:English
Published: BMC 2017-11-01
Series:BMC Cancer
Subjects:
Anal cancer
Hematologic toxicity
Radiotherapy
Dose-painted IMRT
Bone-marrow sparing radiation
Online Access:http://link.springer.com/article/10.1186/s12885-017-3708-4

Internet

http://link.springer.com/article/10.1186/s12885-017-3708-4

Similar Items